SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Beam Therapeutics Reports Third-Quarter 2026 Financial Results

The company also highlighted clinical progress across its base-editing portfolio. Updated BEAM-302 Phase 1/2 data presented at ERS demonstrated durable increases in function.

BEAM
SquawkNews Desk 1 updates Updated Nov 03, 2026, 12:03 PM UTC

Story updates

12:03:59 PM UTC
SquawkNews
Beam Therapeutics 3Q Loss/Shr $1.28 >BEAM

Related stories

Liberty Global Returns to Profit in Q3 2026 Liberty Global returned to profitability in Q3 2026. M impact | EQUITY | Nov 03, 2026, 01:12 PM UTC Sysco Reports Higher Q1 FY27 Net Profit and Revenue Sysco reported year-over-year increases in net profit and revenue in Q1 FY27. M impact | EQUITY | Nov 03, 2026, 01:12 PM UTC Ardmore Shipping Q3 Revenue Beats Estimates on Higher Spot Charter Rates M impact | EQUITY | Nov 03, 2026, 01:12 PM UTC PJT Partners Reports Q3 Adjusted Earnings; Revenue Falls PJT Partners reported Q3 adjusted earnings, and revenue fell. M impact | EQUITY | Nov 03, 2026, 01:12 PM UTC Advanced Info Service Reports Quarterly Attributable Profit of 13.50 Billion Baht M impact | EQUITY | Nov 03, 2026, 01:12 PM UTC Sysco Reports Fiscal Q1 Profit Sysco reported fiscal first-quarter profit, according to The Associated Press. The amount was not provided in the available text. M impact | EQUITY | Nov 03, 2026, 01:12 PM UTC